Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy

Similar Items

• Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy
  by: Vanham Guido, et al.
  Published: (2006-12-01)
• Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
  by: Jallow, S, et al.
  Published: (2007)
• Anti-Retroviral Therapy (ART) Monitoring and the Development of the Oligonucleotide Ligation Assay for Detecting Critical Drug-resistant Mutations in HIV-2 Patients in Preparation of the Global Fund Initiative in The Gambia
  by: Rowland-Jones Sarah, et al.
  Published: (2005-12-01)
• Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.
  by: Jallow, S, et al.
  Published: (2006)
• Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.
  by: Mendy, M, et al.
  Published: (2008)